Lilly Sticks To Clinical Trial Disclosure Commitments, Auditor Finds
This article was originally published in The Pink Sheet Daily
More than 99% of trial results were posted on schedule to the company’s website.
You may also be interested in...
The International Committee of Medical Journal Editors will require that studies be registered at or before patient enrollment in order to be considered for publication. A Sept. 9 editorial notes that only ClinicalTrials.gov currently fits ICMJE registry criteria.
Website will be expanded in the fourth quarter to include results of Lilly-sponsored clinical trials for marketed products, including Phase III data from failed studies of secondary indications.
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13